Tandem Diabetes (TNDM) Misses Q2 EPS by 21c, Revenues Beat; Offers FY20 Revenue Guidance Above Consensus, 3Q Revenues Outlook Below Consensus

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/21/2026

1. SPY
2. WBD
3. PSKY
4. NVDA
5. TSLA
6. USO
7. AMD
8. COHR
9. META
10. AMC

Go back to Tandem Diabetes (TNDM) Misses Q2 EPS by 21c, Revenues Beat; Offers FY20 Revenue Guidance Above Consensus, 3Q Revenues Outlook Below Consensus
TANDEM DIABETES (NASDAQ: TNDM) Delayed: 17.62 +0.75 (4.45%)
Previous Close $16.87    52 Week High $12.48 
Open $17.01    52 Week Low $1.60 
Day High $17.83    P/E N/A 
Day Low $16.60    EPS $-6.33 
Volume 2,101,593